1. Cancer-associated fibroblasts promote the malignant development of lung cancer through the FOXO1 protein/LIF signaling
   Jiannan Shen et al, 2024, International Journal of Biological Macromolecules CrossRef
2. Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities
   Sagun Parakh et al, 2021, Cancers CrossRef
3. The Circular RNA circFOXK2 Enhances the Tumorigenesis of Non-Small Cell Lung Cancer Through the miR-149-3p/IL-6 Axis
   Tongwei Xiang et al, 2024, Biochemical Genetics CrossRef
4. A mechanistic PK/PD model of AZD0171 (anti‐LIF) to support Phase II dose selection
   Azar Shahraz et al, 2024, CPT: Pharmacometrics & Systems Pharmacology CrossRef
5. Circular RNA circEZH2 Promotes Lung Adenocarcinoma Progression by Regulating microRNA-495-3p/Tumor Protein D52 Axis and Activating Nuclear Factor-Kappa B Pathway
   Liping Chen et al, 2024, International Journal of General Medicine CrossRef
6. Identification and genetic validation of leukemia inhibitory factor super‐enhancers in acute respiratory distress syndrome and lung cancer
   Liuting Chen et al, 2024, Cell Biochemistry and Function CrossRef
7. Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer
   Jason Hongting Leung et al, 2022, Cells CrossRef
8. STAT3-specific nanocarrier for shRNA/drug dual delivery and tumor synergistic therapy
   Le Sun et al, 2024, Bioactive Materials CrossRef
9. The Role of Leukemia Inhibitory Factor in Counteracting the Immunopathology of Acute and Chronic Lung Inflammatory Diseases
   Howard Yu et al, 2023, Journal of Respiration CrossRef